Dayton Therapeutics
  • Home
  • Contact
  • Home
  • Contact

Anticancer Research: Satraplatin Demonstrates High Cytotoxic Activity…

mousemin | April 6, 2022

Satraplatin is an oral pl​atinum analog with proven clinical efficacy and a more favorable toxicity profile, although with increased hematotoxicity, when compared to cisplatin…

Categories:
← Nature Reviews: The rediscovery of platinum-based cancer therapy
Healthcare Markets International meets Dr Felix Dahm →
  • Recent Posts

    • Hello world!
  • Recent Comments

    • Home
    • Contact
    Dayton Therapeutics

    © Dayton Therapeutics AG
    Registered Office:
    Sennweidstr. 45
    6312 Steinhausen
    Zug, Switzerland